Quilvest SA was founded in 1915 and is based in Luxembourg, Luxembourg with additional offices in Paris, France; New York, New York; and London, United Kingdom. Quilvest SA is a public investment firm specializing in private equity investments and wealth management. It makes private equity investments through its subsidiary Quilvest Private Equity. The firm offers wealth management services through its subsidiaries Banque Privee Quilvest, Quilvest Switzerland and Quilvest Dubai Ltd.

HSBC Private Bank comprises the private banking operations of UK banking bigwig HSBC Holdings. A subsidiary of principal holding company, HSBC Private Banking Holdings (Suisse) and operating through several subsidiaries of its own, the company specializes in private banking and trustee services such as investment advisory and wealth and tax planning for wealthy individuals and families. Banking services include deposit products, debit and credit cards, lines of credit, loans, high-end residential mortgages and home equity loans, and other related services. HSBC Private Bank group also provides specialty advisory services to charities, foundations, media companies, and diamond and jewelry concerns.

Hercules Technology Growth Capital, Inc. was founded in December 2003 and is headquartered in Palo Alto, California with additional offices across United States. Hercules Technology Growth Capital, Inc. (HTGC) is a specialty finance company that provides debt and equity growth capital to technology-related companies at all stages of development from seed and emerging growth to expansion and established stages of development, which include select publicly listed companies and lower middle market companies. The Company primarily finances privately-held companies backed by venture capital and private equity firms and also may finance certain select publicly-traded companies that lack access to public capital or are sensitive to equity ownership dilution. HTGC sources its investments through its principal office located in Silicon Valley, as well as its additional offices in the Boston and Boulder.

Founded in 1998 by Bill Hambrecht, WR Hambrecht + Co is a financial services firm committed to using technology and auction processes to provide open and fair access to financial markets for all its clients. The firm’s impartial auctions have dramatically changed the traditional investment banking landscape by allowing the market to determine pricing and allocations.The OpenIPO® auction, for example, levels the playing field in initial public offerings, allowing individuals and institutional investors to bid online for shares of an IPO. All investors end up paying the same price – a price determined by the auction. The OpenBook® auction for corporate bonds, is an online system that offers transparent, real-time price discovery. OpenFollowOn® auction extends the transparency and real-time price discovery of the OpenBook auction to follow-on equity offerings allowing interactive bidding and gives investors a view into the book as it builds.WR Hambrecht + Co continues to identify markets where auctions will benefit investors and issuers. WR Hambrecht provide underwriting and advisory services for technology and emerging growth companies, as well as technology driven institutional agency brokerage and a fully electronic retail brokerage platform for individual investors. WR Hambrecht + Co is headquartered in San Francisco with offices in New York, Los Angeles, and Philadelphia. WR Hambrecht Canadian affilliate, WR Hambrecht + Co Canada, is headquartered in Toronto, Ontario, Canada.

OAM Avatar is owned by Overture Asset Managers. OAM Avatar, LLC company offers investments, analysis, and brokerage services for financial planners, institutions, wrap brokerage sponsors, and private clients. It manages more than $1 billion in assets from a portfolio that includes Microsoft, Bank of America, United Technologies, Target, and Johnson & Johnson. Products include equity and balanced brokerage programs, defensive and core equity, mutual funds, and customized services for private clients.

MDY Healthcare PLC previously known as Medisys plc, was listed on the Main Market of the London Stock Exchange in June 2000. Following the sale of its main operating subsidiary, Hypoguard Limited, to ARKRAY Inc. of Japan in May 2006, the company became an investing company. In September 2006, simultaneous with the move across to AIM and the change of name, the company raised £4.7 million (£4.4 million net of expenses) through a subscription for new shares by 3i Group plc and the management team.MDY Healthcare plc is a sector specialised investing company quoted on AIM (ticker symbol: MDY). The company seeks to achieve superior returns for shareholders by investing globally in companies, both public and private, in the healthcare sector, with a particular focus on medical technology. The directors and executives have significant operational and investment experience in the sector and therefore the ability to identify and review a wide range of potential investments. Given the management's experience and contact base within the sector, MDY is also able to provide investee companies with strategic business support and advice over and above finance.

China Resources means "the great land of China, endowed with abundant natural resources". The history of China Resources can be traced back to as early as 1938 when Liow & Company was established in Hong Kong. It was renamed China Resources Company in 1948 and restructured and incorporated under China Resources (Holdings) Co., Ltd. in 1983. In the same year, it relocated to its current headquarters in the China Resources Building on 26 Harbour Road, Wanchai of Hong Kong.Rooted in Hong Kong for over a half century, China Resources has been committed to fostering a better future by observing the proactive and human-oriented ideal. With efforts of many years, China Resources has been grown continuously and established a good business reputation. In over half a century's business in Hong Kong, China Resources has established a strong reputation based on its proactive business strategies, an open corporate culture and a commitment to fostering a better future.Today, it is one of the leading conglomerates in Hong Kong and the Chinese Mainland, with assets totaling around HK$ 240 billion and turnover totaling over HK$ 110 billion. China Resources' businesses touch every facet of people's lives. Its core businesses cover retail, power, breweries, real estate, food, medicine, textiles, chemical products, gas, compressor etc. Moving forward, the company will further develop its core businesses in the Chinese Mainland with Hong Kong as base, striving to become the market leader in each industry. The success of its core businesses will stimulate the further growth of the entire company and create a broader development space.

Cenkos Securities takes stock in its clients and then helps them take stock in the UK market. Through its subsidiaries, Cenkos Securities plc offers financial services and consulting to small- to mid-cap companies. Cenkos Securities plc services include stock brokering, investment advice (with an emphasis on long-term investments), corporate financing advice, and fund management. Cenkos Securities plc also advises on mergers, acquisitions, and other corporate transactions, and makes markets in about 40 stocks on the LSE and other markets. Cenkos Securities plc serves various industries in the UK, including companies in the technology, mining, real estate, and insurance sectors. Cenkos was established in 2004 by chairman Andrew Stewart.

BB BIOTECH AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB BIOTECH AG invests mainly in companies operating in such sectors as oncology, cardiovascular diseases, infectious diseases and autoimmune diseases. As of December 31, 2009, the Company’s portfolio comprised 23 companies, including Actelion, Gilead, Celgene, Genentech, Biogen Idec, Vertex Pharmaceuticals, Elan, Basilea Pharmaceuticals and Roche Holding GS, among others. The investments are held through its wholly owned subsidiaries, which include Biotech Focus NV, Biotech Invest NV, Biotech Target NV and Biotech Growth NV.

First Capital Bancorp, Inc. operates as a holding company for First Capital Bank that offers commercial banking and related financial services to small and medium-sized businesses, professionals, and individuals in Richmond, Virginia. Market Area The company’s primary market is the Richmond, Virginia metropolitan area, which includes Chesterfield County, Henrico County, Hanover County, the Town of Ashland, and the City of Richmond. All of its branches are located in the Richmond metropolitan area. Products and Services The company offers a range of deposit services that include checking accounts, NOW accounts, savings accounts, and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. In addition, it offers certain retirement account services, such as Individual Retirement Accounts (IRAs). The company also offers a range of short-to-medium term commercial and consumer loans. Commercial loans include both secured and unsecured loans for working capital (including inventory and receivables), business expansion (including acquisition of real estate and improvements), and purchase of equipment and machinery. Consumer loans include secured (and unsecured loans) for financing automobiles, home improvements, education, and personal investments. Additionally, it originates fixed and floating-rate mortgage and real estate construction and acquisition loans.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.